Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma

Journal of Thyroid Research

Volumn 2016, Issue , 2016, Pages

  Kobawala, Toral P ^a   Trivedi, Trupti I ^a   Gajjar, Kinjal K ^a   Patel, Darshita H ^a   Patel, Girish H ^a   Ghosh, Nandita R ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD ANALYSIS; CANCER GROWTH; CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; THYROID CARCINOMA;

EID: 84962680561     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.1155/2016/8143695     Document Type: Article

References (91)

1. A. Unnikrishnan andU. Menon, "Thyroid disorders in India: an epidemiological perspective, " Indian Journal of Endocrinology and Metabolism, vol. 15, no. 6, pp. S78-S81, 2011.
2. P. Fallahi, V. Mazzi, R. Vita et al., "New therapies for dedifferentiated papillary thyroid cancer, " International Journal of Molecular Sciences, vol. 16, no. 3, pp. 6153-6182, 2015.
3. V. Erol, O. Makay, G. Icoz et al., "The importance of staging systems for the determination of prognosis of well-differentiated thyroid cancer, " Turkish Journal of Surgery, vol. 29, no. 1, pp. 7-10, 2013.
4. A. Mantovani, "Cancer: inflaming metastasis, " Nature, vol. 457, no. 7225, pp. 36-37, 2009.
5. R. van Horssen, T. L. M. ten Hagen, A. M. M. Eggermont, "TNF-in cancer treatment: molecular insights, antitumor effects, clinical utility, "TheOncologist, vol. 11, no. 4, pp. 397-408, 2006.
6. B. B. Aggarwal, "Signalling pathways of the TNF superfamily: a double-edged sword, " Nature Reviews Immunology, vol. 3, no. 9, pp. 745-756, 2003.
7. M. Baay, A. Brouwer, P. Pauwels, M. Peeters, F. Lardon, "Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy, " Clinical and Developmental Immunology, vol. 2011, Article ID 565187, 12 pages, 2011.
8. G. Sethi, B. Sung, B. B. Aggarwal, "TNF: a master switch for inflammation to cancer, " Frontiers in Bioscience, vol. 13, no. 13, pp. 5094-5107, 2008.
9. F. Balkwill, "Tumour necrosis factor and cancer, " Nature Reviews Cancer, vol. 9, no. 5, pp. 361-371, 2009.
10. Y. D. Wu and B. P. Zhou, "TNF-/NF-B/Snail pathway in cancer cell migration and invasion, " British Journal of Cancer, vol. 102, no. 4, pp. 639-644, 2010.
11. K. Newton and V. M. Dixit, "Signaling in innate immunity and inflammation, " Cold Spring Harbor Perspectives in Biology, vol. 4, Article ID a006049, 2012.
12. N. Makrilia, A. Kollias, L. Manolopoulos, K. Syrigos, "Cell adhesion molecules: role and clinical significance in cancer, " Cancer Investigation, vol. 27, no. 10, pp. 1023-1037, 2009.
13. M. Kelly, J. M. Hwang, P. Kubes, "Modulating leukocyte recruitment in inflammation, " Journal of Allergy and Clinical Immunology, vol. 120, no. 1, pp. 3-10, 2007.
14. I. P. Witz, "Tumor-microenvironment interactions, " in The Link Between Inflammation and Cancer, vol. 130, pp. 125-140, Springer, 2006.
15. J. Laferrière, F. Houle, J. Huot, "Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38, " Annals of the New York Academy of Sciences, vol. 973, pp. 562-572, 2002.
16. Y. Okugawa, C. Miki, Y. Toiyama et al., "Soluble VCAM-1 and its relation to disease progression in colorectal carcinoma, " Experimental and Therapeutic Medicine, vol. 1, no. 3, pp. 463-469, 2010.
17. A. Thielemann, A. Baszczuk, Z. Kopczyski, A. Nowak, S. Grodecka-Gazdecka, "The clinical usefulness of assessing the concentration of cell adhesion molecules sVCAM-1 and sICAM-1 in the serum of women with primary breast cancer, " Contemporary Oncology, vol. 18, no. 4, pp. 252-259, 2014.
18. B.-Z. Qian and J. W. Pollard, "New tricks for metastasisassociated macrophages, " Breast Cancer Research, vol. 14, article 316, 2012.
19. D. R. Rhodes, J. Yu, K. Shanker et al., "Oncomine: a cancer microarray database and integrated data-mining platform, " Neoplasia, vol. 6, no. 1, pp. 1-6, 2004.
20. W. Remmele and H. E. Stegner, "Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue, " Pathologe, vol. 8, pp. 138-140, 1987.
21. R. M. Talaat, T. A. Salem, S. El-Masry, A. Imbarek, M. Mokhles, A. Abdel-Aziz, "Circulating pro-and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma, " Journal of Medical Virology, vol. 86, no. 7, pp. 1120-1129, 2014.
22. M. I. Ahmed, E.-E. Salahy, S. T. Fayed, N. G. El-Hefnawy, A. Khalifa, "Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-, " Clinical Biochemistry, vol. 34, no. 6, pp. 491-498, 2001.
23. D. C. Micheli, P. C. Fernandes Jr., J. C. G. Cruvinel, I. D. Nomelini, E. F. C. Murta, B. M. Tavares-Murta, "Circulating cytokines and nitric oxide are involved in the inhibition of neutrophil migration in patients with uterine cervical neoplasia, " Clinical Medicine Insights: Oncology, vol. 6, pp. 233-242, 2012.
24. P. W. Szlosarek, M. J. Grimshaw, H. Kulbe et al., "Expression and regulation of tumor necrosis factor in normal and malignant ovarian epithelium, " Molecular Cancer Therapeutics, vol. 5, no. 2, pp. 382-390, 2006.
25. B. Dobrzycka, S. J. Terlikowski, O. Kowalczuk, M. Kinalski, "Circulating levels of TNF-and its soluble receptors in the plasma of patients with epithelial ovarian cancer, " European Cytokine Network, vol. 20, no. 3, pp. 131-134, 2009.
26. V. Michalaki, K. Syrigos, P. Charles, J. Waxman, "Serum levels of IL-6 and TNF-correlate with clinicopathological features and patient survival in patients with prostate cancer, " British Journal of Cancer, vol. 90, no. 12, pp. 2312-2316, 2004.
27. N. Yoshida, S. Ikemoto, K. Narita et al., "Interleukin-6, tumour necrosis factor and interleukin-1 in patients with renal cell carcinoma, " British Journal of Cancer, vol. 86, no. 9, pp. 1396-1400, 2002.
28. A. Ferrajoli, M. J. Keating, T. Manshouri et al., "The clinical significance of tumor necrosis factor-plasma level in patients having chronic lymphocytic leukemia, " Blood, vol. 100, no. 4, pp. 1215-1219, 2002.
29. S. Kim, T. O. Keku, C. Martin et al., "Circulating levels of inflammatory cytokines and risk of colorectal adenomas, " Cancer Research, vol. 68, no. 1, pp. 323-328, 2008.
30. F. Linkov, R. L. Ferris, Z. Yurkovetsky et al., "Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases, " Proteomics-Clinical Applications, vol. 2, no. 12, pp. 1575-1585, 2008.
31. F. Lumachi, S. M. M. Basso, R. Orlando, "Cytokines, thyroid diseases and thyroid cancer, " Cytokine, vol. 50, no. 3, pp. 229-233, 2010.
32. A. Agarwal, U. Agrawal, S. Verma, N. K. Mohanty, S. Saxena, "Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre-and postintravesical combination immunotherapy, " Immunopharmacology and Immunotoxicology, vol. 32, no. 2, pp. 348-356, 2010.
33. H. Gendek-Kubiak, J. Grzegorczyk, E. G. Gendek, M. L. Kowalski, J. Berner, "Serum TNF-alpha level in the neoplasm patients qualified for surgical treatment, " Archivum Immunologiae et Therapiae Experimentalis, vol. 49, pp. S97-102, 2001.
34. M. P. DeMiguel, M. Royuela, F. R. Bethencourt, L. Santamar, B. Fraile, R. Paniagua, "Immunoexpression of tumour necrosis factor-and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate, " Cytokine, vol. 12, no. 5, pp. 535-538, 2000.
35. G. Soria, M. Ofri-Shahak, I. Haas et al., "Inflammatory mediators in breast cancer: coordinated expression of TNF& IL-1 with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition, " BMC Cancer, vol. 11, article 130, 2011.
36. G. Rodruez-Berriguete, B. Snchez-Espiridin, J. R. Cansino et al., "Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-signaling pathways in prostate cancer, " Cytokine, vol. 64, no. 2, pp. 555-563, 2013.
37. K. Hbel, G. Mansmann, H. Schfer, F. Oberhuser, V. Diehl, A. Engert, "Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF, " Cytokine, vol. 12, no. 12, pp. 1797-1800, 2000.
38. P. Rzymski, T. Opala, M. Wilczak, J. Woniak, S. Sajdak, "Serum tumor necrosis factor alpha receptors p55/p75 ratio and ovarian cancer detection, " International Journal of Gynecology and Obstetrics, vol. 88, no. 3, pp. 292-298, 2005.
39. A. M. Filho, M. P. Jammal, E. de Castro Cobo et al., "Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer, " Immunology Letters, vol. 158, no. 1-2, pp. 195-199, 2014.
40. I. Garc-Tuñn, M. Ricote, A. Ruiz, B. Fraile, R. Paniagua, M. Royuela, "Role of tumor necrosis factor-and its receptors in human benign breast lesions and tumors (in situ and infiltrative), " Cancer Science, vol. 97, no. 10, pp. 1044-1049, 2006.
41. B. Zubelewicz, M. Muc-Wierzgon, J. Wierzgon et al., "Genetic disregulation of gene coding tumor necrosis factor alpha receptors (TNF alpha Rs) in follicular thyroid cancer-preliminary report, " Journal of Biological Regulators andHomeostatic Agents, vol. 16, pp. 98-104, 2002.
42. Y. Dong, M. Guo, Z. Wang, "Clinical significance of measurements of changes of serum e-cad, sICAM-I, L-Selectin and VEGF levels after operation in patients with ovarian cancer, " Fangshe Mianyixue Zazhi, vol. 21, pp. 268-270, 2008.
43. A. Izycka, E. Jaboska, T. Izycki, E. Chyczewska, "Estimation of L-selectin expression on surface of neutrophils stimulated by TNF-and level of sL-selectin in serum of patients with lung cancer, " Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego, vol. 18, no. 103, pp. 62-65, 2005.
44. B. Kiersnowska-Rogowska, A. Izycka, E. Jaboska, F. Rogowski, A. Parfieczyk, "Estimation of L-selectin expression on neutrophils and level of soluble L-selectin form in serum of patient with chronic myelogenic leukemia, " Przegld Lekarski, vol. 63, no. 9, pp. 756-758, 2005.
45. S. Aref, O. Salama, Y. Al-Tonbary, M. Fouda, A. Menessy, M. El-Sherbiny, "L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome, " Hematology, vol. 7, no. 2, pp. 83-87, 2002.
46. L. Chen, Y. Zhou, J. Xue, T. Jiang, D. Zhong, "Expressions of intercellular adhesionmolecule-1 and L-selection in lung carcinoma and their clinical significance, " The Journal of Practical Medicine, vol. 23, pp. 4049-4051, 2008.
47. Q. Wang and Y. Li, "Clinical significance of measurements of changes of serum SICAM-1, L-selectin and VEGF levels after operative treatment in patients with primary liver cancer, " Journal of Radioimmunology, vol. 19, pp. 526-527, 2006.
48. D. Choudhary, P. Hegde, O. Voznesensky et al., "Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: a potential marker for metastatic disease, " Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 9, pp. 387. e17-387. e27, 2015.
49. Z. Pasieka, K. Kuzdak, W. Czyz, H. Steie, J. Komorowski, "Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer, " Neoplasma, vol. 51, no. 1, pp. 34-37, 2004.
50. F. Zhou, J. Chen, G. Tao, M. Zhu, W. Xie, X. Cao, "Increased levels of exhaled sICAM1, sVCAM1, sE-selectin in patients with non-small cell lung cancer, " Respiratory Medicine, vol. 108, no. 11, pp. 1670-1676, 2014.
51. D. M. O'Hanlon, H. Fitzsimons, J. Lynch, S. Tormey, C. Malone, H. F. Given, "Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma, " European Journal of Cancer, vol. 38, no. 17, pp. 2252-2257, 2002.
52. O. Kemik, A. S. Kemik, I. Hasirci, M. Adas S. Purisa, A. C. Dlger, "Serum level of soluble vascular adhesion molecule 1 in patients with rectal cancer, " European Journal of General Medicine, vol. 8, no. 2, pp. 105-109, 2011.
53. D. Alexiou, A. J. Karayiannakis, K. N. Syrigos et al., "Clinical significance of serumlevels of E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1 in gastric cancer patients, "The American Journal of Gastroenterology, vol. 98, no. 2, pp. 478-485, 2003.
54. Y.-B. Ding, G.-Y. Chen, J.-G. Xia, X.-W. Zang, H.-Y. Yang, L. Yang, "Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma, " World Journal of Gastroenterology, vol. 9, no. 7, pp. 1409-1414, 2003.
55. D. Alexiou, A. J. Karayiannakis, K. N. Syrigos et al., "Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery, " European Journal of Cancer, vol. 37, no. 18, pp. 2392-2397, 2001.
56. M. Roselli, F. Guadagni, F. Martini et al., "Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer, " Oncology, vol. 65, no. 2, pp. 132-138, 2003.
57. L. Holubec Jr., O. Topolcan, J. Finek et al., "Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma, " Anticancer Research, vol. 25, no. 3, pp. 1597-1601, 2005.
58. V. Dymicka-Piekarska, K. Guzinska-Ustymowicz, A. Kuklinski, H. Kemona, "Prognostic significance of adhesionmolecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients, " Thrombosis Research, vol. 129, no. 4, pp. e47-e50, 2012.
59. S.-Q. Liu, Y.-J. Su, M.-B. Qin, Y.-B. Mao, J.-A. Huang, G.-D. Tang, "Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules, " International Journal of Oncology, vol. 42, no. 2, pp. 617-626, 2013.
60. R. S. Svatek, C. Jeldres, P. I. Karakiewicz et al., "Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence, " Prostate, vol. 69, no. 8, pp. 886-894, 2009.
61. U. Coskun, B. Sancak, I. Sen et al., "Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages, " International Immunopharmacology, vol. 6, no. 4, pp. 672-677, 2006.
62. F. Perabo, S. Sharma, R. Gierer et al., "Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies, " Indian Journal of Cancer, vol. 38, no. 1, pp. 1-7, 2001.
63. T. Kawano, S. Yanoma, Y. Nakamura et al., "Evaluation of soluble adhesionmolecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, VCAM-1 as tumor markers in head and neck cancer, " The American Journal of Otolaryngology-Head and Neck Medicine and Surgery, vol. 26, no. 5, pp. 308-313, 2005.
64. K. Markocka-Maczka, "Concentration of serum soluble forms of ICAM-1 (sVCAM-1) and VCAM-1 (sVCAM-1) in patients with chronic pancreatitis and in patients with pancreatic carcinoma, " Wiadomosci Lekarskie, vol. 56, no. 3-4, pp. 147-151, 2002.
65. M. Jakimovska, K. Cerne, I. Verdenik, B. Kobal, "Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites, " Radiology and Oncology, vol. 48, no. 3, pp. 307-313, 2014.
66. L. M. Martinez, V. B. F. Vallone, V. Labovsky et al., "Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases, " Clinical and Experimental Metastasis, vol. 31, no. 2, pp. 213-232, 2014.
67. F. Tas, S. Karabulut, M. Serilmez, R. Ciftci, D. Duranyildiz, "Clinical significance of serumepithelial cell adhesionmolecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer, " Tumor Biology, vol. 35, no. 4, pp. 3095-3102, 2014.
68. H. Y. Zhang, S. C. Li, Q. Zhong, "Study of the expression and correlation of L-selectin in oral squamous cell carcinoma and salivary gland malignant tumor, " Journal of Oral Science Research, vol. 10, p. 12, 2014.
69. X. Wu, K. Li, F. Zhang, J. C. Liu, Y. Y. Lin, C. T. Jin, "Expression of CCR7, L-selectin, CD44v6 and MMP9 in colorectal cancer and their relative with lymphatic metastatic, " Chinese Journal of Clinical and Experimental Pathology, vol. 1, p. 12, 2013.
70. Z. Miao, A. Qiu, X. Wang, L. Wang, Y. Shi, Q. Xu, "Expression of L-selectin in sentinel lymph node of breast cancer and its clinical significance, " Chinese Journal of General Surgery, vol. 5, article 017, 2012.
71. H. Lubli, K.-S. Spanaus, L. Borsig, "Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotesmetastasis through recruitment ofmonocytes, " Blood, vol. 114, no. 20, pp. 4583-4591, 2009.
72. H. Lubli and L. Borsig, "Selectins promote tumor metastasis, " Seminars in Cancer Biology, vol. 20, no. 3, pp. 169-177, 2010.
73. K. J. Garton, P. J. Gough, J. Philalay et al., "Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-converting enzyme (ADAM 17), " The Journal of Biological Chemistry, vol. 278, no. 39, pp. 37459-37464, 2003.
74. M. Lieuw-a-Fa, C. Schalkwijk, V. W. M. van Hinsbergh, "Distinct accumulation patterns of soluble forms of E-selectin, VCAM-1 and ICAM-1 upon infusion of TNF in tumor patients, "Thrombosis and Haemostasis, vol. 89, no. 6, pp. 1052-1058, 2003.
75. J. Huang, J. Zhang, H. Li et al., "VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer, " American Journal of Translational Research, vol. 5, no. 3, pp. 336-346, 2013.
76. P.-C. Wang, C.-C. Weng, Y.-S. Hou et al., "Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells, " International Journal of Molecular Sciences, vol. 15, no. 3, pp. 3560-3579, 2014.
77. J. M. Scalici, S. Thomas, C. Harrer et al., "Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer, " Journal of Nuclear Medicine, vol. 54, no. 11, pp. 1883-1889, 2013.
78. A. A. Tempia-Caliera, L. Z. Horvath, A. Zimmermann et al., "Adhesion molecules in human pancreatic cancer, " Journal of Surgical Oncology, vol. 79, no. 2, pp. 93-100, 2002.
79. L. Sun, F. Wang, L. Liu, Y. Song, Y. Yang, L. Wang, "Expression and significance of vascular cell adhesion molecule-1 in human oral squamous cell carcinoma, " West China Journal of Stomatology, vol. 26, no. 6, pp. 591-594, 2008.
80. K.-I. Shioi, A. Komiya, K. Hattori et al., "Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients, " Clinical Cancer Research, vol. 12, no. 24, pp. 7339-7346, 2006.
81. J. Shin, J. Kim, B. Ryu, S.-G. Chi, H. Park, "Caveolin-1 is associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells, " Cellular Physiology and Biochemistry, vol. 17, no. 5-6, pp. 211-220, 2006.
82. N. D. Melendez, B. R. Smoller, M. Morgan, "VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas, " Modern Pathology, vol. 16, no. 1, pp. 8-13, 2003.
83. K. Li, C. Jin, G. Zhang, X. Zhao, R. Bai, B. Liu, "Expression and significance of CCR7 and L-selectin in human colorectal carcinoma tissue, " Shandong Medical Journal, vol. 7, article 014, 2012.
84. J. W. Ho, R. T. Poon, C. S. Tong, S. T. Fan, "Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma, " World Journal of Gastroenterology, vol. 10, no. 14, pp. 2014-2018, 2004.
85. M. A. Bewick, M. Conlon, H. Lee et al., "Evaluation of sICAM-1, sVCAM-1, sE-selectin levels in patients with metastatic breast cancer receiving high-dose chemotherapy, " Stem Cells and Development, vol. 13, no. 3, pp. 281-294, 2004.
86. L. Borsig, "Selectins facilitate carcinomametastasis and heparin can prevent them, " Physiology, vol. 19, no. 1, pp. 16-21, 2004.
87. P. Radhakrishnan, V. Chachadi, M.-F. Lin, R. Singh, R. Kannagi, P.-W. Cheng, "TNF enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl-and sulfotransferase genes involved in the synthesis of selectin ligands, " Biochemical and Biophysical Research Communications, vol. 409, no. 3, pp. 436-441, 2011.
88. J. Haier, T. Korb, B. Hotz, H.-U. Spiegel, N. Senninger, "An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation, " Journal of Gastrointestinal Surgery, vol. 7, no. 4, pp. 507-515, 2003.
89. J. W. Sturm, R. Magdeburg, K. Berger et al., "Influence of TNFA on the formation of livermetastases in a syngenicmouse model, " International Journal of Cancer, vol. 107, no. 1, pp. 11-21, 2003.
90. K. Schlter, P. Gassmann, A. Enns et al., "Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential, " The American Journal of Pathology, vol. 169, no. 3, pp. 1064-1073, 2006.
91. S. Ali, J. Kaur, K. D. Patel, "Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation, " The American Journal of Pathology, vol. 157, no. 1, pp. 313-321, 2000.